📊 PETVW Key Takeaways
Is PetVivo Holdings, Inc. (PETVW) a Good Investment?
PetVivo exhibits strong early-stage revenue growth (+415% YoY) with healthy gross margins (62.2%), but faces an acute financial crisis: cash position of only $18.2K cannot sustain annual operating losses of $6.1M and negative cash burn of $5.3M, creating imminent liquidity risk. Without immediate capital injection or dramatic operational turnaround, the company faces critical solvency challenges.
PetVivo Holdings, Inc. Key Strengths (PETVW)
- Strong revenue growth of 415% YoY demonstrates significant market traction and customer acquisition
- Gross margin of 62.2% indicates strong product-level unit economics and pricing power
- Improving operational trajectory with EPS loss narrowing 47.4% YoY suggests cost management progress
PETVW Stock Risks: PetVivo Holdings, Inc. Investment Risks
- Critical liquidity crisis: $18.2K cash against $5.3M annual operating cash burn implies runway of weeks, not months
- Massive operating losses of $6.1M (operating margin -687.9%) unsustainable without external funding
- Negative free cash flow (-$5.3M) indicates company cannot self-fund operations and requires continuous capital raises
- Total assets of only $4.4M provide minimal financial cushion or collateral for distressed financing
- 12 Form 4 insider filings in 90 days suggests heightened insider activity or potential governance concerns
Key Metrics to Watch
- Cash position and monthly cash burn rate - critical near-term solvency indicator
- Gross margin sustainability as revenue scales - product economics validation
- Path to operating profitability with revenue growth - unit economics viability
- Capital raise announcements or debt financing - survival metric for pre-profitable stage
PetVivo Holdings, Inc. (PETVW) Financial Metrics & Key Ratios
💡 AI Analyst Insight
PetVivo Holdings, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
PETVW Profit Margin, ROE & Profitability Analysis
PETVW vs Healthcare Sector: How PetVivo Holdings, Inc. Compares
How PetVivo Holdings, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is PetVivo Holdings, Inc. Stock Overvalued? PETVW Valuation Analysis 2026
Based on fundamental analysis, PetVivo Holdings, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
PetVivo Holdings, Inc. Balance Sheet: PETVW Debt, Cash & Liquidity
PETVW Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: PetVivo Holdings, Inc.'s revenue has grown significantly by 8,904% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.78 indicates the company is currently unprofitable.
PETVW Revenue Growth, EPS Growth & YoY Performance
PETVW Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $286.1K | -$1.8M | $-0.07 |
| Q2 2026 | $200.7K | -$2.0M | $-0.11 |
| Q1 2026 | $123.8K | -$2.0M | $-0.09 |
| Q3 2025 | $583.3K | -$1.7M | $-0.09 |
| Q2 2025 | $200.7K | -$2.0M | $-0.11 |
| Q1 2025 | $117.2K | -$2.0M | $-0.11 |
| Q3 2024 | $510.1K | -$1.7M | $-0.12 |
| Q2 2024 | $207.4K | -$2.0M | $-0.21 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
PetVivo Holdings, Inc. Dividends, Buybacks & Capital Allocation
PETVW SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for PetVivo Holdings, Inc. (CIK: 0001512922)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PETVW
What is the AI rating for PETVW?
PetVivo Holdings, Inc. (PETVW) has an AI grade of D with 88% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PETVW's key strengths?
Claude: Strong revenue growth of 415% YoY demonstrates significant market traction and customer acquisition. Gross margin of 62.2% indicates strong product-level unit economics and pricing power.
What are the risks of investing in PETVW?
Claude: Critical liquidity crisis: $18.2K cash against $5.3M annual operating cash burn implies runway of weeks, not months. Massive operating losses of $6.1M (operating margin -687.9%) unsustainable without external funding.
What is PETVW's revenue and growth?
PetVivo Holdings, Inc. reported revenue of $886.9K.
Does PETVW pay dividends?
PetVivo Holdings, Inc. does not currently pay dividends.
Where can I find PETVW SEC filings?
Official SEC filings for PetVivo Holdings, Inc. (CIK: 0001512922) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PETVW's EPS?
PetVivo Holdings, Inc. has a diluted EPS of $-0.27.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is PETVW's fundamental grade?
Based on our AI fundamental analysis in June 2026, PetVivo Holdings, Inc. has a D grade with 88% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is PETVW stock overvalued or undervalued?
Valuation metrics for PETVW: ROE of -222.3% (sector avg: 15%), net margin of -846.8% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is PETVW's AI grade for 2026?
Our dual AI analysis gives PetVivo Holdings, Inc. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PETVW's free cash flow?
PetVivo Holdings, Inc.'s operating cash flow is $-5.3M, with capital expenditures of $7.7K. FCF margin is -597.9%.
How does PETVW compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -846.8% (avg: 12%), ROE -222.3% (avg: 15%), current ratio 1.40 (avg: 2).